Frontal cortical synaptophysin in Lewy body diseases: Relation to Alzheimer's disease and dementia

Journal of Neurology Neurosurgery and Psychiatry

Volumn 64, Issue 5, 1998, Pages 653-656

  Hansen, L A ^a,e   Daniel, S E ^b   Wilcock, G K ^c   Love, S ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Institute of Neurology   (United Kingdom)

^c Department of Care of the Elderly ^*

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dementia; Lewy body disease; Synaptophysin

Indexed keywords

SYNAPTOPHYSIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN STEM; CONTROLLED STUDY; DEMENTIA; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NEOCORTEX; NEUROPATHOLOGY; PRIORITY JOURNAL; SYNAPSE;

EID: 0031922359     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.64.5.653     Document Type: Article

References (24)

1. Hughes AJ, Daniel SE, Blankson S, et al. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140-53.
2. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-24.
3. Hansen, LA, Samuel W. Criteria for Alzheimer disease and the nosology of dementia with Lewy bodies. Neurology 1997;48:126-32.
4. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology 1990;40:1-8.
5. Salmon DP, Galasko D, Hansen LA, et al. Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn 1996;31:148-65.
6. Samuel W, Alford M, Hofstetter R, et al. Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density. J Neuropathol Exp Neurol 1997;56:41-50.
7. Terry RD, Masliah E, Salmon D, et al. Physical basis of cognitive alterations in Alzheimer disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30:572-80.
8. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-105.
9. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease. Arch Pathol Lab Med 1993;117:132-44.
10. Alford MF, Masliah E, Hansen LA, et al. A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain. J Histochim Cytochem 1994;42:283-7.
11. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59.
12. Banshor C, Braak H, Fischer P, et al. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci Lett 1993;162:179-82.
13. Lantos PL, Ovenstone IMK, Johnson J, et al. Lewy bodies in the brain of two members of a family with the 171 (Val to Ile) mutation of the amyloid precursor protein gene. Neurosci Lett 1994;172:77-9.
14. Bodhireddy S, Dickson DW, Mattiace L, et al. A case of Down's syndrome with diffuse Lewy body disease and Alzheimer's disease. Neurology 1994;44:159-61.
15. Gearing M, Schneider JA, Rebec GW, et al. Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates. Neurology 1995;45:1985-90.
16. Galasko D, Saitoh T, Xia Y, et al. The apolipoprotein E allele ε4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994;44:1950.
17. Nalbantoglu J, Gilfix BM, Bertrand P, et al. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann Neurol 1994;36:889-95.
18. Perry EK, Curtis M, Dick DJ, et al. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry 1985;48:413-21.
19. Perry EK, Marshall E, Perry RH, et al. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alzheimer Dis Assoc Disord 1990;4:87-95.
20. Perry EK, McKeith I, Thompson P, et al. Topography, extent and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Ann NY Acad Sci 1991;640:197-202.
21. Samuel W, Galasko D, Masliah E, et al. Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol 1996;55:44-52.
22. Lennox G, Lowe J, Landon M, et al. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistiy. J Neurol Neurosurg Psychiatry 1989; 52:1236-17.
23. Weiner MF, Risser RC, Cullum CM. et al. Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases. Am J Psychiatry 1996;153: 1269-73.
24. Scatton B, Rouquier L, Javoy-Agid F, et al. Dopamine deficieny in the cerebral cortex in Parkinson disease. Neurology 1982;23:1039-40.